DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Zhao J, Tan W, Zhang L. et al.
FGFR3 phosphorylates EGFR to promote cisplatin-resistance in ovarian cancer.
Biochem Pharmacol 2021; (e-pub ahead of print)
DOI: 10.1016/j.bcp.2021.114536.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.